Cancer Research at the Fralin Biomedical Research Institute
At the Fralin Biomedical Research Institute, dedicated investigators in two centers strive to improve therapies and better outcomes in a range of cancers, from childhood cancers to breast cancer to brain cancers, including acute myeloid leukemia, diffuse midline glioma, and glioblastoma multiforme. Research teams are exploring drug development, the role of genes in cancer, focused ultrasound and biomatarials to improve existing cancer treatments such as immunotherapy. With laboratories in Roanoke, Virginia, and Washington, D.C., the research institute devotes significant resources to making groundbreaking discoveries to address the challenges of the second leading cause of death globally.
-
Home Item
Jenny Munson, Ph.D. , homeProfessor, Director, Cancer Research Center – Roanoke
-
Home Item
Christopher Hourigan, DM, DPhil, FRCP , homeProfessor, Director, Cancer Research Center – D.C.
-
Article Item
-
Article Item
-
Article Item
-
Article ItemFocused Ultrasound Foundation names Virginia Tech as a Center of Excellence , article
Virginia Tech becomes the sixth Focused Ultrasound Center of Excellence in the United States and one of only 12 in the world.
Date: Jun 04, 2024 -
Article ItemFralin Biomedical Research Institute scientist to co-chair international forum on gap junctions , article
Co-chairs James Smyth and Silvia Penuela are bringing scientists from across the globe to Arlington to share findings in a rapidly developing field whose insights point to novel therapeutic opportunities in a wide range of disorders and complex diseases.
Date: May 24, 2024 -
Article ItemResearchers reveal promising treatment target for resistant brain cancer , article
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem. But now, Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC may have moved a step closer to a solution.
Date: May 17, 2024 -
Article ItemFralin Biomedical Research Institute at VTC and Virginia Tech shine as innovations receive TechNite acclaim , article
The Roanoke-Blacksburg Technology Council’s TechNite awards turned a spotlight on translational research taking place at Fralin Biomedical Research Institute at VTC and throughout the region.
Date: May 15, 2024 -
Article ItemTesting for residual cancer cells before blood cell transplant therapy is important and practical, new study finds , article
Patients in remission after battling blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells. The finding in JAMA Oncology emphasizes the importance of testing for lingering cancer cells in the body after people receive apparently successful chemotherapy treatment.
Date: May 02, 2024 -
Article ItemFralin Biomedical Research Institute’s new lab will take aim at tobacco use, cancer rates, and informing policy , article
Roberta Freitas-Lemos wants to provide policymakers with research-informed strategies to influence health behavior and lower cancer rates related to tobacco, one of the world’s biggest public health threats.
Date: Apr 17, 2024 -
Article ItemVirginia Tech professor to be inducted into prestigious American Society for Clinical Investigation , article
Christopher Hourigan, director of the Cancer Research Center – D.C., has been inducted into the American Society for Clinical Investigation, a historic membership for a faculty member of Virginia Tech.
Date: Apr 04, 2024
Page 1 of 10 | 95 Results
Recent Media Coverage
-
Redirect Item
-
Redirect Item
-
Redirect ItemFinancial News: Tobacco Firms: Preying on the Poor? , redirect Date: Jun 07, 2024
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
Page 1 of 18 | 179 Results